advanced search
2023_Dec_DDL_Edinburgh_leaderboard

Ophthalmic Drug Delivery48

Issue No #48  April 8th, 2014


Download PDF


Inside the magazine

CURRENT AND FUTURE OPHTHALMIC FORMULATION AND PROCESS DEVELOPMENT TRENDS
OCULAR
Brian McMillan
CoreRx
CURRENT AND FUTURE OPHTHALMIC FORMULATION AND PROCESS DEVELOPMENT TRENDS
Brian McMillan provides some insights into his personal experiences in the development of ophthalmic products and the significant role of innovative delivery systems in improving efficacy and reducing side-effects.
ZERO-ORDER SUSTAINED DRUG DELIVERY TO THE RETINA FROM A NANOPOROUS FILM DEVICE
OCULAR
Dr Daniel A Bernards
Oculinea
ZERO-ORDER SUSTAINED DRUG DELIVERY TO THE RETINA FROM A NANOPOROUS FILM DEVICE
Daniel Bernards, Robert Bhisitkul and Tejal Desai discuss the development of a nanoporous membrane-based implant which can significantly improve drug delivery to the back of the eye.
REVIEW OF PRESENT TECHNOLOGIES & STEPS FORWARD
OCULAR
Dr Shikha P Barman
Integral BioSystems
REVIEW OF PRESENT TECHNOLOGIES & STEPS FORWARD
Shikha Barman provides an overview of the current state of play in the ocular drug delivery market.
IMPROVING OUTCOMES IN OPHTHALMOLOGY VIA SUSTAINED DRUG DELIVERY
OCULAR
Dr Tomas Navratil
IMPROVING OUTCOMES IN OPHTHALMOLOGY VIA SUSTAINED DRUG DELIVERY
Tomas Navratil, Benjamin Maynor and Benjamin Yerxa describe the company’s particle engineering technology and its application in improving the delivery of prostaglandin analogues and anti-VEGF therapy.
REDUCE RISKS, MITIGATE FAILURE & DRIVE TIMELINES IN A COMPETITIVE MARKET
OCULAR
Badre Hammond
Next Breath
REDUCE RISKS, MITIGATE FAILURE & DRIVE TIMELINES IN A COMPETITIVE MARKET
Badre Hammond, Shailuja Somaraju and Julie Suman highlight key considerations and present strategies to reduce risk and ultimately accelerate the process for gaining approval of an ophthalmic product, with a focus on the US.
COMPANY PROFILE: ENCOMPASS
OCULAR
Rick Coulon
Encompass Pharmaceutical Services
COMPANY PROFILE: ENCOMPASS
Encompass Pharma, based in Norcross, GA, US, was formed in 2004 by a highly experienced team of ophthalmic development and analytical scientists.
MICRO OPHTHALMIC OCULAR IMPLANTS
OCULAR
Donna Bibber
Micro Engineering Solutions
MICRO OPHTHALMIC OCULAR IMPLANTS
Donna Bibber explores one market segment in which micro manufacturing has played and will continue to play a significant role in worldwide growth in the next five years … ophthalmic devices.
BREAKTHROUGH NANOTECHNOLOGY ENHANCES DELIVERY TO THE FRONT AND BACK OF THE EYE
OCULAR
Dr Robert Langer
Kala Pharmaceuticals
BREAKTHROUGH NANOTECHNOLOGY ENHANCES DELIVERY TO THE FRONT AND BACK OF THE EYE
Hongming Chen and Robert Langer discuss applications of the company’s Mucus Penetrating Particle nanotechnology in ophthalmic drug delivery.
Top